脱细胞真皮基质在腹壁重建中提供持久长期结局:随访超过60个月患者的研究
该回顾性队列研究纳入2005至2019年接受猪或牛脱细胞真皮基质腹壁重建的725例患者,分析疝复发和手术部位并发症。中位随访显示1、3、5、7年累积疝复发率分别为4.9%、13.5%、17.3%、18.8%,两种基质间无差异,肥胖、桥接修补和造口是复发独立预测因素。
要点
- 脱细胞真皮基质用于复杂腹壁重建,长期疝复发率相对较低。
- 猪源与牛源脱细胞真皮基质在疝复发和手术部位并发症上无差异。
- 肥胖、桥接修补、合并造口是疝复发的独立预测因素,组织分离技术有保护作用。
核心结论
- 尽管用于复杂腹壁重建,脱细胞真皮基质仍提供持久的长期结局,疝复发率相对较低。
研究设计与样本
- 回顾性队列研究,纳入2005至2019年接受猪或牛脱细胞真皮基质腹壁重建的患者,共725例。
- 分析全队列及至少随访5年的亚组(n=162)。
主要发现
- 全队列中93例(13%)发生疝复发,1、3、5、7年累积复发率分别为4.9%、13.5%、17.3%、18.8%。
- 27%的患者发生手术部位并发症。
- 猪源与牛源脱细胞真皮基质间疝复发(P=0.83)和手术部位并发症(P=0.87)无差异。
- 长期随访亚组(n=162)疝复发率为16%。
- 肥胖、桥接修补、合并造口存在/创建是疝复发的独立预测因素;组织分离技术对疝复发有保护作用。
临床怎么用
- 脱细胞真皮基质可用于复杂腹壁重建,长期复发率可接受。
- 选择猪源或牛源脱细胞真皮基质时,疝复发和手术部位并发症风险相似。
- 对肥胖、需桥接修补或合并造口的患者应警惕疝复发风险,组织分离技术可能降低复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventral hernia repair (VHR) is one of the most commonly performed procedures in the United States, but studies assessing the long-term outcomes of VHR using biologic mesh are scarce. OBJECTIVE: We sought to determine the rates of hernia recurrence (HR) and surgical site occurrences (SSOs) in a large cohort of patients who underwent AWR with biologic mesh. METHODS: We conducted a retrospective cohort study of patients who underwent AWR using either porcine ADM (PADM) or bovine ADM (BADM) from 2005 to 2019. We analyzed the full cohort and a subset of our population with minimum long-term follow-up (LTF) of 5 years. The primary outcome measure was HR. Secondary outcomes were SSOs. RESULTS: We identified a total of 725 AWRs (49.5% PADM, 50.5% BADM). Mean age was 69 ± 11.5 years and mean body mass index was 31 ± 7 kg/m 2 . Forty-two percent of the defects were clean at the time of AWR, 44% were clean-contaminated, and 14% were contaminated/infected. Mean defect size was 180 ± 174 cm 2 , mean mesh size was 414 ± 203 cm 2 . Hernia recurred in 93 patients (13%), with cumulative HR rates of 4.9%, 13.5%, 17.3%, and 18.8% at 1, 3, 5, and 7 years, respectively. There were no differences in HR ( P = 0.83) and SSO ( P = 0.87) between the 2 mesh types. SSOs were identified in 27% of patients. In our LTF group (n = 162), the HR rate was 16%. Obesity, bridged repair, and concurrent stoma presence/creation were independent predictors of HR; component separation was protective against HR. CONCLUSIONS: Despite its use in complex AWR, ADM provides durable long-term outcomes with relatively low recurrence rates.
引用
- Asaad M, Kapur SK, Baumann DP, et al. Acellular Dermal Matrix Provides Durable Long-Term Outcomes in Abdominal Wall Reconstruction: A Study of Patients with Over 60 Months of Follow-up. Ann Surg. 2020. PMID: 33086319. doi:10.1097/SLA.0000000000004454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。